title: New drugs and product approvals from 1999.
authors.affiliation: Department of Oral & Maxillofacial Surgery & Pharmacology, Baylor College of Dentistry, Texas A&M University System Health Science Center, USA.
authors.forename: T W
authors.initials: TW
authors.lastname: Gage
authors.forename: S E
authors.initials: SE
authors.lastname: Taylor
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002491:Central Nervous System Agents / Q000627:therapeutic use; D018679:Cholinergic Agonists / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D018795:Device Approval; D004304:Dosage Forms; D017277:Drug Approval; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D014481:United States; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D001993:Bronchodilator Agents; D002491:Central Nervous System Agents; D018679:Cholinergic Agonists; D003879:Dermatologic Agents; D004304:Dosage Forms; D005765:Gastrointestinal Agents; D006728:Hormones; D007166:Immunosuppressive Agents; D014665:Vasodilator Agents